These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 2070805)
1. Evaluation of therapeutic response using iodine-131-B72.3 monoclonal antibody in patients with ovarian carcinoma. Camera L; Del Vecchio S; Petrillo A; Esposito G; Frasci G; Iaffaioli RV; Bianco AR; Salvatore M Eur J Nucl Med; 1991; 18(4):269-73. PubMed ID: 2070805 [TBL] [Abstract][Full Text] [Related]
2. Clinical studies with B72.3 in ovarian cancer and probe-guided tumor localization. Del Vecchio S; Camera L; Petrillo A; Esposito G; Frasci G; Iaffaioli RV; Bianco AR; Salvatore M Int J Rad Appl Instrum B; 1991; 18(1):85-7. PubMed ID: 2010311 [TBL] [Abstract][Full Text] [Related]
3. Diagnosis of ovarian cancer with radiolabelled monoclonal antibodies: our experience using 131I-B72.3. Mansi L; Panza N; Lastoria S; Pacilio G; Salvatore M Int J Rad Appl Instrum B; 1989; 16(2):127-35. PubMed ID: 2715006 [TBL] [Abstract][Full Text] [Related]
4. The use of radiolabelled monoclonal antibodies to human milk fat globule membrane antigens in antibody-guided tumour imaging, and administration of therapeutic dose of labelled antibody in wide-spread ovarian carcinoma. A preliminary report. Ashorn R; Ashorn P; Punnonen R; Pöyhönen L; Turjanmaa V; Koskinen M; Helle M; Uusitalo A; Pystynen P; Krohn K Ann Chir Gynaecol Suppl; 1985; 197():5-10. PubMed ID: 3863532 [TBL] [Abstract][Full Text] [Related]
5. Tumour-associated monoclonal antibodies for the diagnosis and assessment of ovarian cancer. Shepherd JH; Granowska M; Britton KE; Mather S; Epenetos AA; Ward BG; Slevin M Br J Obstet Gynaecol; 1987 Feb; 94(2):160-7. PubMed ID: 3828255 [TBL] [Abstract][Full Text] [Related]
6. Antibody-guided radiolocalisation of tumours in patients with testicular or ovarian cancer using two radioiodinated monoclonal antibodies to placental alkaline phosphatase. Epenetos AA; Carr D; Johnson PM; Bodmer WF; Lavender JP Br J Radiol; 1986 Feb; 59(698):117-25. PubMed ID: 3947819 [TBL] [Abstract][Full Text] [Related]
7. A preliminary study of radioimmunoimaging by 131I-COC183B2 monoclonal antibody in patients with epithelial ovarian cancer. Qian HN; Feng J; Cui H; Gao BS; Qin SL; Fu TY; Wei P; Fu ZY; Gao SM; Yang ZY Chin Med J (Engl); 1991 Feb; 104(2):109-13. PubMed ID: 1874008 [TBL] [Abstract][Full Text] [Related]
8. Intraoperative radioimmunodetection of ovarian cancer using monoclonal antibody B72.3 and a portable gamma-detecting probe. Bell J; Mojzisik C; Hinkle G; Derman H; Schlom J; Martin E Obstet Gynecol; 1990 Oct; 76(4):607-11. PubMed ID: 2216188 [TBL] [Abstract][Full Text] [Related]
9. A prospective imaging study of 131I-B72.3 monoclonal antibody in patients with epithelial ovarian cancer: preliminary report. Lastoria S; D'Amico P; Mansi L; Giordano GG; Rossiello R; Schlom J; Pace E; Panza N; Pacilio G; Salvatore M Nucl Med Commun; 1988 May; 9(5):347-56. PubMed ID: 2842708 [TBL] [Abstract][Full Text] [Related]
10. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity. Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726 [TBL] [Abstract][Full Text] [Related]
11. The role of radioimmunoscintigraphy and computed tomography scan prior to reassessment laparotomy of patients with ovarian carcinoma. A preliminary report. Method MW; Serafini AN; Averette HE; Rodriguez M; Penalver MA; Sevin BU Cancer; 1996 Jun; 77(11):2286-93. PubMed ID: 8635097 [TBL] [Abstract][Full Text] [Related]
12. Immunoscintigraphy with 131I-labelled monoclonal antibodies HMFG2 and HMFG1 F(ab')2 versus abdominal CT scan in the detection of residual disease in ovarian cancer patients. Pectasides D; Pateniotis K; Tzimis L; Trapalli X; Natsis P; Arapantoni P; Taylor-Papadimitriou J; Epenetos A; Koutsiouba P; Athanassiou A Int J Cancer Suppl; 1988; 3():83-8. PubMed ID: 3209305 [TBL] [Abstract][Full Text] [Related]
14. Clinical implications for immunoscintigraphy in patients with ovarian malignancy: a preliminary study using monoclonal antibody 791T/36. Symonds EM; Perkins AC; Pimm MV; Baldwin RW; Hardy JG; Williams DA Br J Obstet Gynaecol; 1985 Mar; 92(3):270-6. PubMed ID: 3978057 [TBL] [Abstract][Full Text] [Related]
15. Use of radiolabelled monoclonal antibodies in patients with primary and metastatic large bowel cancer. Sergile SL; Haller DG; Daly JM Surg Oncol; 1992 Dec; 1(6):391-8. PubMed ID: 1341276 [TBL] [Abstract][Full Text] [Related]
16. Orthotopic xenografts of human melanoma and colonic and ovarian carcinoma in sheep to evaluate radioimmunotherapy. Turner JH; Rose AH; Glancy RJ; Penhale WJ Br J Cancer; 1998 Aug; 78(4):486-94. PubMed ID: 9716032 [TBL] [Abstract][Full Text] [Related]
17. Endobronchial administration of iodine-131 B72.3 monoclonal antibody in patients with lung cancer. Del Vecchio S; Mansi L; Petrillo A; Camera L; Sofia M; Marra A; Carratù L; Salvatore M Eur J Nucl Med; 1991; 18(2):129-32. PubMed ID: 2044572 [TBL] [Abstract][Full Text] [Related]
18. Targeting of tumours with murine and reshaped human monoclonal antibodies against placental alkaline phosphatase: immunolocalisation, pharmacokinetics and immune response. Kalofonos HP; Kosmas C; Hird V; Snook DE; Epenetos AA Eur J Cancer; 1994; 30A(12):1842-50. PubMed ID: 7880616 [TBL] [Abstract][Full Text] [Related]
19. The use of monoclonal antibody B72.3 in the management of gynecologic malignancies. Simpson J; Schlom J Yale J Biol Med; 1988; 61(4):351-66. PubMed ID: 3055701 [TBL] [Abstract][Full Text] [Related]
20. Localization and imaging of radiolabeled monoclonal antibodies against colorectal carcinoma in tumor-bearing nude mice. Buchsbaum D; Lloyd R; Juni J; Wollner I; Brubaker P; Hanna D; Spicker J; Burns F; Steplewski Z; Colcher D Cancer Res; 1988 Aug; 48(15):4324-33. PubMed ID: 3390828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]